HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helen V Danesh-Meyer Selected Research

Herpes Zoster Ophthalmicus

10/2022Prompt Antiviral Therapy Is Associated With Lower Risk of Cerebrovascular Accident Following Herpes Zoster Ophthalmicus.
3/2021Ethylenediaminetetraacetic Acid Chelation in Herpes Zoster Ophthalmicus Is Associated With a High Rate of Corneal Melt and Perforation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Helen V Danesh-Meyer Research Topics

Disease

13Glaucoma
05/2022 - 04/2006
11Optic Nerve Diseases (Optic Neuropathy)
01/2022 - 06/2004
8Inflammation (Inflammations)
01/2019 - 03/2006
5Disease Progression
01/2018 - 07/2011
5Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
09/2012 - 06/2003
4Open-Angle Glaucoma (Glaucoma, Open Angle)
08/2014 - 01/2010
3Ganglion Cysts (Ganglion)
11/2019 - 01/2010
3Diabetic Retinopathy (Retinopathy, Diabetic)
01/2019 - 03/2016
3Macular Degeneration (Age-Related Maculopathy)
10/2017 - 04/2008
2Herpes Zoster Ophthalmicus
10/2022 - 03/2021
2Uveitis
01/2022 - 03/2021
2Cataract (Cataracts)
12/2020 - 01/2013
2Gliosis
01/2019 - 01/2018
2Ischemia
10/2017 - 10/2015
2Edema (Dropsy)
10/2017 - 03/2016
2Wounds and Injuries (Trauma)
10/2017 - 04/2014
2Hypoxia (Hypoxemia)
04/2014 - 02/2012
2Neoplasms (Cancer)
04/2014 - 05/2008
2Reperfusion Injury
03/2012 - 02/2012
2Optic Nerve Injuries
06/2011 - 11/2008
2Erectile Dysfunction
07/2009 - 11/2007
1Exanthema (Rash)
10/2022
1Stroke (Strokes)
10/2022
1Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
01/2022
1Eye Diseases (Eye Disease)
01/2022
1Weight Loss (Weight Reduction)
01/2022
1Scleritis (Episcleritis)
01/2022
1Corneal Perforation
03/2021
1Neuromyelitis Optica (Devic's Disease)
03/2021
1Band-Shaped Corneal Dystrophy
03/2021
1Conjunctivitis
01/2021
1COVID-19
12/2020
1Geographic Atrophy
01/2019
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2018
1Neuroinflammatory Diseases
10/2017
1Migraine Disorders (Migraine)
10/2017
1Mucolipidoses (Sialidosis)
09/2016
1Retinal Diseases
03/2016
1Nervous System Trauma
01/2016
1Huntington Disease (Huntington's Disease)
11/2015
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
10/2015
1Headache (Headaches)
10/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2014
1Chronic Disease (Chronic Diseases)
04/2014
1Myasthenia Gravis
02/2014
1Carcinoma (Carcinomatosis)
07/2013
1Ocular Hypertension (Glaucoma, Suspect)
01/2013
1Blister (Bulla)
01/2013
1Fibrosis (Cirrhosis)
08/2012
1Cicatrix (Scar)
08/2012
1Spinal Cord Injuries (Spinal Cord Injury)
02/2012
1Pupil Disorders (Marcus Gunn Pupil)
10/2010
1Pituitary Neoplasms (Pituitary Adenoma)
06/2009
1Infarction (Infarctions)
04/2008

Drug/Important Bio-Agent (IBA)

19Retinaldehyde (Retinal)IBA
01/2022 - 12/2006
15Connexin 43 (Connexin43)IBA
01/2019 - 11/2008
3ConnexinsIBA
10/2017 - 01/2014
3Peptides (Polypeptides)IBA
01/2016 - 07/2013
3Biomarkers (Surrogate Marker)IBA
11/2015 - 09/2012
2Acetazolamide (Diamox)FDA LinkGeneric
01/2022 - 01/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2016 - 02/2014
2Drinking WaterIBA
01/2010 - 09/2008
2Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
07/2009 - 11/2007
2Phosphodiesterase 5 InhibitorsIBA
07/2009 - 11/2007
1Antiviral Agents (Antivirals)IBA
10/2022
1Myelin-Oligodendrocyte GlycoproteinIBA
03/2021
1Edetic Acid (EDTA)FDA Link
03/2021
1Immunoglobulin G (IgG)IBA
03/2021
1CannabinoidsIBA
03/2021
1Viral RNAIBA
01/2021
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2020
1InflammasomesIBA
01/2019
1CytokinesIBA
01/2018
1Antiglaucoma AgentsIBA
01/2018
1tonabersatIBA
10/2017
1Adenosine Triphosphate (ATP)IBA
10/2017
1OligosaccharidesIBA
09/2016
1salicylhydroxamic acid (SHAM)IBA
01/2016
114-3-3 Proteins (14-3-3 Protein)IBA
10/2015
1AcidsIBA
10/2015
1Ophthalmic Solutions (Eye Drops)IBA
09/2015
1Angiogenesis InhibitorsIBA
04/2014
13-nitrotyrosineIBA
01/2014
1CalciumIBA
01/2014
1Propidium (Propidium Iodide)IBA
07/2013
1OligodeoxyribonucleotidesIBA
08/2012
1Intravenous Immunoglobulins (IVIG)FDA Link
07/2011
1AntibodiesIBA
01/2011

Therapy/Procedure

6Therapeutics
10/2022 - 06/2004
4Trabeculectomy (Trabeculoplasty)
05/2022 - 09/2008
3Radiotherapy
04/2014 - 06/2004
3Lasers (Laser)
04/2010 - 12/2006
2Phacoemulsification
12/2020 - 01/2013
2Intravitreal Injections
01/2018 - 10/2015
2Aftercare (After-Treatment)
04/2008 - 06/2004
1Elective Surgical Procedures
12/2020
1Anesthesia
12/2020
1Surgical Decompression
11/2019
1Stents
10/2014
1Transjugular Intrahepatic Portasystemic Shunt
01/2013